Banish hERGphobia: Using Systems Pharmacology to Assess Cardiac Safety
Is the era of “hERGphobia” finally coming to an end? 薬物性の心血管系副作用は、医薬品の市場撤退の主な原因の1つであり、医薬品添付文書における使用制限に関連する事項の1つでもあります。As a result, biopharmaceutical companies are keen to identify new drug candidates with a propensity to cause arrhythmias, or the heart to beat with … Continued